Location: New York, NY
CIK: 0001952142 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value: $314M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ROIV | ROIVANT SCIENCES LTD | 2,578,860 | $26.02M | 8.3% | $10.18 | +6.3% | SHS | G76279101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,598,594 | $19.64M | 6.3% | $17.25 | -18.3% | COM | 87164F105 |
| SRRK | SCHOLAR ROCK HLDG CORP | 566,212 | $18.2M | 5.8% | $36.74 | +4.7% | COM | 80706P103 |
| ACLX | ARCELLX INC | 273,774 | $17.96M | 5.7% | $67.74 | 0.0% | COMMON STOCK | 03940C100 |
| — | MERUS N V | 346,756 | $14.59M | 4.7% | $39.75 | — | COM | N5749R100 |
| IMVT | IMMUNOVANT INC | 853,472 | $14.59M | 4.6% | $31.46 | -33.5% | COM | 45258J102 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 40,936 | $13.56M | 4.3% | $328.59 | 0.0% | COM | 558868105 |
| NUVL | NUVALENT INC | 190,401 | $13.5M | 4.3% | $89.78 | -12.9% | COM | 670703107 |
| RVMD | REVOLUTION MEDICINES INC | 318,782 | $11.27M | 3.6% | $46.22 | -12.2% | COM | 76155X100 |
| JANX | JANUX THERAPEUTICS INC | 342,062 | $9.236M | 2.9% | $39.68 | -5.0% | COM | 47103J105 |
| XENE | XENON PHARMACEUTICALS INC | 274,633 | $9.214M | 2.9% | $41.35 | -8.2% | COM | 98420N105 |
| DNLI | DENALI THERAPEUTICS INC | 667,078 | $9.069M | 2.9% | $22.35 | -14.3% | COM | 24823R105 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 593,335 | $8.532M | 2.7% | $16.65 | — | SPONSORED ADS | 152309100 |
| QURE | UNIQURE NV | 731,039 | $7.749M | 2.5% | $13.36 | +5.0% | SHS | N90064101 |
| BBIO | BRIDGEBIO PHARMA INC | 208,437 | $7.206M | 2.3% | $33.72 | 0.0% | COM | 10806X102 |
| CGON | CG ONCOLOGY INC | 289,823 | $7.102M | 2.3% | $28.13 | 0.0% | COM | 156944100 |
| — | SPRINGWORKS THERAPEUTICS INC | 159,305 | $7.03M | 2.2% | $44.13 | — | COM | 85205L107 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 440,073 | $6.883M | 2.2% | $5.99 | +135.3% | COM | 03969K108 |
| INSM | INSMED INC | 87,059 | $6.642M | 2.1% | $72.02 | +6.2% | COM PAR $.01 | 457669307 |
| ALKS | ALKERMES PLC | 192,352 | $6.351M | 2.0% | $28.50 | +14.4% | SHS | G01767105 |
| — | AKERO THERAPEUTICS INC | 156,185 | $6.322M | 2.0% | $40.48 | — | COM | 00973Y108 |
| BHVN | BIOHAVEN LTD | 250,564 | $6.024M | 1.9% | $36.20 | -2.6% | COM | G1110E107 |
| CYTK | CYTOKINETICS INC | 149,648 | $6.014M | 1.9% | $49.66 | -7.5% | COM NEW | 23282W605 |
| — | BLUEPRINT MEDICINES CORP | 61,927 | $5.481M | 1.7% | $88.51 | — | COM | 09627Y109 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,366,554 | $5.112M | 1.6% | $3.60 | -21.3% | COM | 92840H400 |
| TARA | PROTARA THERAPEUTICS INC | 1,190,579 | $5.072M | 1.6% | $4.05 | +10.3% | COM STK | 74365U107 |
| KALV | KALVISTA PHARMACEUTICALS INC | 386,837 | $4.464M | 1.4% | $10.36 | -1.5% | COM | 483497103 |
| EWTX | EDGEWISE THERAPEUTICS INC | 180,255 | $3.966M | 1.3% | $28.77 | -8.8% | COM | 28036F105 |
| SRZN | SURROZEN INC | 240,826 | $2.808M | 0.9% | $10.29 | +12.9% | COM NEW | 86889P208 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 49,241 | $2.381M | 0.8% | $43.60 | -3.9% | COM | 74366E102 |
| ELVN | ENLIVEN THERAPEUTICS INC | 120,430 | $2.37M | 0.8% | $25.06 | -14.1% | COM | 29337E102 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 21,052 | $2.328M | 0.7% | $126.68 | 0.0% | COM | 64125C109 |
| ASND | ASCENDIS PHARMA A/S | 14,732 | $2.296M | 0.7% | $155.86 | — | SPONSORED ADR | 04351P101 |
| BBOT | HELIX ACQUISITION CORP II | 200,900 | $2.27M | 0.7% | $10.35 | +3.8% | CL A ORD SHS | G4444H101 |
| SYRE | SPYRE THERAPEUTICS INC | 136,139 | $2.197M | 0.7% | $20.81 | 0.0% | COM NEW | 00773J202 |
| FOLD | AMICUS THERAPEUTICS INC | 268,919 | $2.194M | 0.7% | $9.25 | 0.0% | COM | 03152W109 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 104,585 | $2.141M | 0.7% | $22.23 | 0.0% | ORDINARY SHARES | N62509109 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 33,816 | $1.791M | 0.6% | $53.78 | +3.2% | COM | 76243J105 |
| ABUS | ARBUTUS BIOPHARMA CORP | 467,882 | $1.633M | 0.5% | $3.33 | 0.0% | COM | 03879J100 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 150,000 | $1.545M | 0.5% | $10.07 | +1.8% | CL A ORD SHS | G70077105 |
| GERN | GERON CORP | 960,307 | $1.527M | 0.5% | $2.44 | 0.0% | COM | 374163103 |
| IDYA | IDEAYA BIOSCIENCES INC | 66,999 | $1.097M | 0.3% | $21.31 | 0.0% | COM | 45166A102 |
| ZLAB | ZAI LAB LTD | 26,421 | $955K | 0.3% | $36.14 | — | ADR | 98887Q104 |
| OCUL | OCULAR THERAPEUTIX INC | 124,523 | $913K | 0.3% | $7.69 | 0.0% | COM | 67576A100 |
| DYN | DYNE THERAPEUTICS INC | 84,430 | $883K | 0.3% | $14.30 | 0.0% | COM | 26818M108 |
| SLNO | SOLENO THERAPEUTICS INC | 11,155 | $797K | 0.3% | $48.69 | 0.0% | COM | 834203309 |
| IFRX | INFLARX NV | 725,019 | $740K | 0.2% | $1.89 | 0.0% | COM | N44821101 |
| SLDB | SOLID BIOSCIENCES INC | 198,150 | $733K | 0.2% | $4.28 | 0.0% | COM NEW | 83422E204 |
| WVE | WAVE LIFE SCIENCES LTD | 89,833 | $726K | 0.2% | $10.28 | +6.4% | SHS | Y95308105 |
| MBX | MBX BIOSCIENCES INC | 96,615 | $713K | 0.2% | $10.57 | 0.0% | COM | 55287L101 |
| SION | SIONNA THERAPEUTICS INC | 60,000 | $628K | 0.2% | $16.34 | 0.0% | COM | 829401108 |
| BCAX | BICARA THERAPEUTICS INC | 47,078 | $613K | 0.2% | $13.28 | 0.0% | COM | 055477103 |
| EWTX | EDGEWISE THERAPEUTICS INC | 50,000 | $238K | 0.1% | $28.77 | -8.8% | Put | 28036F105 |
| CVS | CVS HEALTH CORP | 64,100 | $165K | 0.1% | — | — | Put | 126650100 |
| MLYS | MINERALYS THERAPEUTICS INC | 125,000 | $93,750 | 0.0% | $13.08 | -12.0% | Put | 603170101 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 100,000 | $42,500 | 0.0% | $5.99 | +135.3% | Call | 03969K108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 100,000 | $32,500 | 0.0% | $10.36 | -1.5% | Call | 483497103 |
| BBC | ETFIS SER TR I | 132,500 | $16,563 | 0.0% | — | — | Call | 26923G301 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 10,000 | $15,500 | 0.0% | $53.78 | +3.2% | Call | 76243J105 |
| MRK | MERCK & CO INC | 151,700 | $8,344 | 0.0% | — | — | Call | 58933Y105 |
| NVO | NOVO-NORDISK A S | 151,700 | $3,793 | 0.0% | — | — | Call | 670100205 |